| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
ATAD5
|
ATPase family, AAA domain containing 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CA9
|
carbonic anhydrase IX
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CBX1
|
chromobox homolog 1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CLSPN
|
claspin
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL4A
|
cullin 4A
|
|
CUL4B
|
cullin 4B
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
E2F3
|
E2F transcription factor 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENDOG
|
endonuclease G
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR1
|
estrogen receptor 1
|
|
FAM111A
|
family with sequence similarity 111, member A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FXYD3
|
FXYD domain containing ion transport regulator 3
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HK2
|
hexokinase 2
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLTF
|
helicase-like transcription factor
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0101
|
KIAA0101
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MUTYH
|
mutY homolog
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME4
|
NME/NM23 nucleoside diphosphate kinase 4
|
|
NTHL1
|
nth endonuclease III-like 1 (E. coli)
|
|
NUDT15
|
nudix (nucleoside diphosphate linked moiety X)-type motif 15
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10
|
|
PAXIP1
|
PAX interacting (with transcription-activation domain) protein 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PGR
|
progesterone receptor
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD2
|
polymerase (DNA directed), delta 2, accessory subunit
|
|
POLD3
|
polymerase (DNA-directed), delta 3, accessory subunit
|
|
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLN
|
polymerase (DNA directed) nu
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PURA
|
purine-rich element binding protein A
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RB1
|
retinoblastoma 1
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SHH
|
sonic hedgehog
|
|
SHPRH
|
SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SPRTN
|
SprT-like N-terminal domain
|
|
TDG
|
thymine-DNA glycosylase
|
|
TERT
|
telomerase reverse transcriptase
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
UBC
|
ubiquitin C
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YBX1
|
Y box binding protein 1
|
|
ZRANB3
|
zinc finger, RAN-binding domain containing 3
|
